Our results clearly showed that AT13387 not only reduced the in vivo tumor formation, but also reduced the formation and growth of NPC tumor spheres accompanied by reduced expression of cancer stem-like cells markers CD44 and SOX2. This evidence concerns the gene CD44 and neoplasm.